Switching Virally Suppressed, Treatment-Experienced Patients to a Raltegravir-Containing Regimen Does Not Alter Levels of HIV-1 DNA

BACKGROUND: Current HIV-1 antiretroviral therapy (ART) greatly reduces virus replication but does not significantly affect the viral reservoir. Raltegravir, a recently introduced integrase inhibitor, could, at least theoretically, reduce residual viremia in patients on ART and affect the viral reser...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Yu Ming Paul, McBride, Kristin L., Amin, Janaki, Cordery, Damien V., Kelleher, Anthony D., Cooper, David A., Koelsch, Kersten K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291553/
https://www.ncbi.nlm.nih.gov/pubmed/22396745
http://dx.doi.org/10.1371/journal.pone.0031990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291553/
https://www.ncbi.nlm.nih.gov/pubmed/22396745
http://dx.doi.org/10.1371/journal.pone.0031990

Ejemplares similares